Skip to main navigation
Skip to search
Skip to main content
Maastricht University Home
Support & FAQ
Link opens in a new tab
Search content at Maastricht University
Home
Researchers
Publications
Activities
Press/Media
Prizes
Organisations
Dataset/Software
Projects
Selenium for preventing cancer
M. Vinceti
*
, G. Dennert
, C.M. Crespi
, M. Zwahlen
, M. Brinkman
,
M.P. Zeegers
, M. Horneber
, R. D'Amico
, C. Del Giovane
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Selenium for preventing cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Selenium
100%
Confidence Interval
81%
Randomized Controlled Trial
63%
Risk Ratio
45%
Odds Ratio
36%
Risk of Bias
36%
Selenium Supplementation
36%
Cancer Risk
27%
Low Risk
27%
Prostate Cancer
27%
Cancer Types
18%
Cancer Mortality
18%
Prostate
9%
Mortality Risk
9%
Issue 1
9%
Genetic Factors
9%
Beneficial Effects
9%
Confounding
9%
Gender Differences
9%
Cancer Clinical Trials
9%
MEDLINE
9%
Causal Relations
9%
Random-effects Meta-analysis
9%
Embase
9%
Type 2 Diabetes Risk
9%
Low Incidence
9%
Healthy Adults
9%
Random Effects
9%
Intervention Effect
9%
Stomach
9%
Adult Participants
9%
Prospective Observational Study
9%
Ovid
9%
Cochrane
9%
Vitamin E
9%
Gender-specific
9%
Non-melanoma Skin Cancer
9%
Site-specific Cancer
9%
Inverse Association
9%
Selenium Levels
9%
Selenium Status
9%
Cochrane Central Register of Controlled Trials
9%
Nested Case-control Study
9%
Dermatitis
9%
Blood Selenium
9%
Electronic Search
9%
Cancer Incidence
9%
Alopecia
9%
Ottawa
9%
Chemical Form
9%
Newcastle
9%
Metalloids
9%
Nutritional Properties
9%
Toxicological Properties
9%
Nutritional Prevention
9%
Inconsistent Results
9%
Medicine and Dentistry
Randomized Controlled Trial
100%
Malignant Neoplasm
100%
Odds Ratio
57%
Prostate Cancer
42%
Supplementation
28%
Observational Study
28%
Cancer Risk
28%
Meta-Analysis
14%
Systematic Review
14%
Maturity Onset Diabetes of the Young
14%
Cancer
14%
Cancer Mortality
14%
Sex Difference
14%
Cancer Types
14%
Cancer Incidence
14%
Alpha Tocopherol
14%
Metalloid
14%
Alopecia Mucinosa
14%
Dermatitis
14%
Non Melanoma Skin Cancer
14%
Case-Control Study
14%
INIS
cancer
100%
risks
100%
selenium
100%
prostate
22%
humans
16%
reviews
16%
women
11%
mortality
11%
control
11%
interventions
11%
randomness
11%
hypothesis
11%
men
11%
data
5%
levels
5%
increasing
5%
intake
5%
blood
5%
males
5%
assessments
5%
investigations
5%
genetics
5%
adults
5%
statistics
5%
handbooks
5%
stomach
5%
vitamin e
5%
skin cancer
5%
melanomas
5%
dermatitis
5%
metalloids
5%
Nursing and Health Professions
Confidence Interval
100%
Malignant Neoplasm
100%
Odds Ratio
44%
Prostate Cancer
33%
Supplementation
22%
Meta Analysis
11%
Cochrane Library
11%
Systematic Review
11%
Non Insulin Dependent Diabetes Mellitus
11%
Case-Control Study
11%
Cancer Mortality
11%
Gender Difference
11%
Selenium Blood Level
11%
Cancer Incidence
11%
Alpha Tocopherol
11%
Dermatitis
11%
Alopecia
11%
Non Melanoma Skin Cancer
11%
Metalloid
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Randomized Controlled Trial
87%
Prostate Cancer
37%
Observational Study
25%
Normal Human
12%
Case-Control Study
12%
Cancer Mortality
12%
Alpha Tocopherol
12%
Cancer Incidence
12%
Dermatitis
12%
Alopecia
12%
Non Melanoma Skin Cancer
12%
Metalloid
12%
Non Insulin Dependent Diabetes Mellitus
12%
Neuroscience
Randomized Controlled Trial
100%
Prostate
14%
Meta-Analysis
14%
Vitamin E
14%
Food Science
Selenium
100%
Vitamin E
5%